WebOct 30, 2024 · Oct 30 (Reuters) - Hikma Pharmaceuticals Plc: * U.S. unit west-ward pharmaceuticals has launched pantoprazole sodium for injection, 40mg Source text for Eikon: Further company coverage: WebOct 29, 2010 · The acquired business will be rolled into Hikma’s wholly owned U.S. subsidiary, West-Ward Pharmaceuticals. The acquired products are primarily sold across the U.S., but Hikma says it will...
BRIEF-Hikma says US unit launched pantoprazole sodium for …
WebDec 30, 2024 · Hikma Pharmaceuticals USA Inc. Rx only WARNINGS Etoposide should be administered under the supervision of a qualified physician experienced in the use of cancer chemotherapeutic agents. Severe myelosuppression with resulting infection or bleeding may occur. DESCRIPTION WebApr 5, 2024 · In connection with the settlement, Jazz has granted Hikma and its wholly owned subsidiary, West-Ward Pharmaceuticals Corp. (West-Ward), the right to sell an authorized generic (AG) version of Xyrem in the U.S. under the Xyrem New Drug Application (NDA), commencing on January 1, 2024, or earlier under certain circumstances customary … malas cabine easyjet
Xerostomia (Dry Mouth Disease) Therapeutics Market Report
Hikma Pharmaceuticals plc is a British multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products. It was founded by Samih Darwazah in Amman, Jordan in 1978. It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index. WebApr 6, 2024 · DUBLIN, April 5, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that certain of its subsidiaries have entered into agreements with … WebApr 13, 2024 · Hikma Pharmaceuticals Stock Up 1.6 %. Shares of HIK opened at GBX 1,804.50 ($22.35) on Wednesday. The firm has a market cap of £3.98 billion, a P/E ratio of 2,651.49, a P/E/G ratio of 2.38 and a ... malas cabine american tourister